Australia markets open in 3 hours 59 minutes

Zhejiang Jiuzhou Pharmaceutical Co., Ltd (603456.SS)

Shanghai - Shanghai Delayed price. Currency in CNY
Add to watchlist
15.92-0.28 (-1.73%)
At close: 03:00PM CST
Currency in CNY

Valuation measures4

Market cap (intra-day) 14.57B
Enterprise value 12.23B
Trailing P/E 14.73
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)2.78
Price/book (mrq)1.68
Enterprise value/revenue 2.33
Enterprise value/EBITDA 10.76

Trading information

Stock price history

Beta (5Y monthly) 0.12
52-week change 3-48.99%
S&P500 52-week change 328.04%
52-week high 332.02
52-week low 314.56
50-day moving average 317.19
200-day moving average 323.15

Share statistics

Avg vol (3-month) 316.03M
Avg vol (10-day) 316.92M
Shares outstanding 5899.49M
Implied shares outstanding 6915.31M
Float 8512.24M
% held by insiders 142.97%
% held by institutions 121.73%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 40.4
Forward annual dividend yield 42.47%
Trailing annual dividend rate 30.50
Trailing annual dividend yield 33.09%
5-year average dividend yield 41.23
Payout ratio 436.36%
Dividend date 3N/A
Ex-dividend date 411 July 2023
Last split factor 21.8:1
Last split date 312 Apr 2018

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 18.85%
Operating margin (ttm)18.01%

Management effectiveness

Return on assets (ttm)5.25%
Return on equity (ttm)11.71%

Income statement

Revenue (ttm)5.25B
Revenue per share (ttm)5.84
Quarterly revenue growth (yoy)-15.70%
Gross profit (ttm)N/A
EBITDA 1.35B
Net income avi to common (ttm)989.32M
Diluted EPS (ttm)1.10
Quarterly earnings growth (yoy)-15.70%

Balance sheet

Total cash (mrq)4.06B
Total cash per share (mrq)4.51
Total debt (mrq)1.72B
Total debt/equity (mrq)19.64%
Current ratio (mrq)2.71
Book value per share (mrq)9.63

Cash flow statement

Operating cash flow (ttm)766.98M
Levered free cash flow (ttm)-988.73M